A carregar...
Vipidia is a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
The global number of patients with diabetes mellitus (DM) has been growing steadily. Over the past decade, the number has more than doubled and reached 371 million people by 2013. [1] In most cases it is type 2 diabetes. The dangerous consequences of DM include micro- and macrovascular complications...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
Remedium Group LLC
2015-12-01
|
| Colecção: | Медицинский совет |
| Assuntos: | |
| Acesso em linha: | https://www.med-sovet.pro/jour/article/view/122 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|